Bristol-Myers Squibb Co.’s quarterly profit and 2005 forecast missed Wall Street estimates on Friday, a day after the company warned it may abandon an experimental diabetes drug.
Bristol-Myers posted third-quarter income of $964 million (49 cents per share), compared with $755 million (38 cents) a year earlier. Excluding items, the drugmaker earned 31 cents per share, two cents below the consensus estimate.